Akanda Corp (AKAN) has released an update.
Akanda Corp. has successfully sold its Portuguese subsidiary RPK to Somai Pharmaceuticals Ltd. for $2 million, along with the assumption of approximately €4 million in debt. The transaction enhances Akanda’s financial stability and enables further focus on its UK subsidiary Canmart and the development of the Gabriola Green Project in Canada. This sale marks a strategic shift for Akanda, positioning it for anticipated growth in the global cannabis market.
For further insights into AKAN stock, check out TipRanks’ Stock Analysis page.
